100 related articles for article (PubMed ID: 2417877)
1. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
Falkenburg JH; Fibbe WE; Veenhof WF; Koning F; van Eeden G; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):101-7. PubMed ID: 2417877
[TBL] [Abstract][Full Text] [Related]
2. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
3. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
Falkenburg JH; van der Vaart-Duinkerken N; Veenhof WF; Goselink HM; van Eeden G; Parlevliet J; Jansen J
Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
[TBL] [Abstract][Full Text] [Related]
4. Discordant expression of human Ia-like antigens on hematopoietic progenitor cells.
Linch DC; Nadler LM; Luther EA; Lipton JM
J Immunol; 1984 May; 132(5):2324-9. PubMed ID: 6609195
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antigenic determinants on human myeloid colony forming cells with monoclonal antibodies.
Greenberg P; Grossman M; Charron D; Levy R
Exp Hematol; 1981 Aug; 9(7):781-7. PubMed ID: 6172283
[TBL] [Abstract][Full Text] [Related]
6. HLA-class II antigens on hemopoietic and stromal cells in human micro long-term bone marrow cultures.
Brühl P; Mergenthaler HG; Ellwart J; Dörmer P
Exp Hematol; 1990 Feb; 18(2):103-8. PubMed ID: 2303101
[TBL] [Abstract][Full Text] [Related]
7. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
8. Studies on the use of nonhuman primates to determine the DR status of the human hematopoietic stem cell.
Winton EF; Colenda KW; McClure HM; Chan WC; Gordon DS
Exp Hematol; 1985 Oct; 13(9):869-73. PubMed ID: 3862599
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
10. Selective expression of class-II MHC antigens during hemopoietic differentiation.
Katz FE; Davis L; Myers CD; Greaves MF
Exp Hematol; 1985 Dec; 13(11):1182-7. PubMed ID: 3864642
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
12. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
13. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
15. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
16. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to HLA-A,B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells.
Fitchen JH; Ferrone S; Quaranta V; Molinaro GA; Cline MJ
J Immunol; 1980 Nov; 125(5):2004-8. PubMed ID: 6159398
[TBL] [Abstract][Full Text] [Related]
18. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
19. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
20. Identification of anti-DQ alloantisera correlated with DR5.
Crepaldi T; Fasano ME; Frattasio C; Centis D; Curtoni ES; Richiardi P
J Immunogenet; 1985 Dec; 12(6):301-8. PubMed ID: 2426368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
